Preprint Review Version 1 This version is not peer-reviewed

Cytokines and Madness: A Unifying Hypothesis of Schizophrenia Involving Interleukin-22

Version 1 : Received: 1 November 2024 / Approved: 4 November 2024 / Online: 5 November 2024 (09:14:56 CET)

How to cite: Sfera, A.; Thomas, K. A.; Anton, J. Cytokines and Madness: A Unifying Hypothesis of Schizophrenia Involving Interleukin-22. Preprints 2024, 2024110219. https://doi.org/10.20944/preprints202411.0219.v1 Sfera, A.; Thomas, K. A.; Anton, J. Cytokines and Madness: A Unifying Hypothesis of Schizophrenia Involving Interleukin-22. Preprints 2024, 2024110219. https://doi.org/10.20944/preprints202411.0219.v1

Abstract

Schizophrenia is a severe neuropsychiatric illness of uncertain etiopathogenesis in which antipsychotic drugs can attenuate the symptoms, but patients rarely return to the premorbid level of functioning. In fact, with each relapse, people living with schizophrenia progress toward disability and cognitive impairment. We hypothesize that poor outcomes in schizophrenia reflect gray matter volume reduction, which continues despite treatment. We further hypothesize that aryl hydrocarbon receptor phosphorylates signal transducer and transcription-three protein, suppressing the gut barrier protectors, including brain-derived neurotrophic factor and interleukin-22. We construe that recombinant human IL-22 can improve schizophrenia outcome by the following actions: 1. Averting microbial translocation outside the gastrointestinal tract by optimizing the gut barrier permeability. 2. Upregulation of BDNF, a neurotrophin lowered in schizophrenia. 3. Downregulation of interferon-gamma, a cytokine elevated in patients with schizophrenia. 4. Acceleration of wound healing and long-term memory formation via STAT3-induced inflammatory responses. This short review examines the influence of IL-22 and BDNF on the STAT3 /AhR axis. Based on the hypothesis described here, we discuss alternative SCZ interventions, including aryl hydrocarbon receptor antagonists, mitochondrial transplant, membrane lipid replacement, and recombinant human IL-22.

Keywords

IL-22; gut permeability; microbial translocation; schizophrenia; hypothesis; gut permeability; aryl hydrocarbon receptor

Subject

Medicine and Pharmacology, Neuroscience and Neurology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.